Abstract:e23171 Background: Among patients with locally advanced nasopharyngeal carcinoma (NPC) in endemic Southern China area, 30.0%-50.0% subset would develop recurrence or metastasis within 5 years after treatment. Identification recurrence related molecules might allow for timely identification of recurrence and target therapy for NPC. Methods: To identify candidate recurrence related molecules, we profiled global gene expression in NPC with a patient survival dataset. On the basis of The Cancer Genome Atlas (TCGA) analysis, we further selected the molecules with high risk for NPC recurrence. Moreover, xenograft animal model and 130 locally advanced NPC patients samples were used to validate the potential to target the selected molecules to prevent NPC recurrence. Results: Based on TCGA analysis and our previously constructed database, we selected 30 molecules that might be contributed to NPC recurrence: Cyclin D1, 14-3-3σ, Aurora-A, CENP-H, Stathmin, P21, CDC2, P27, ERK, p-ERK, Ki-67, E-Cadherin, β-Catenin, N-Cadherin, Snail, Twist, C-Met, nm23-H1, HIF-1α, COX2, MMP-2, MMP-9, TIMP-2, Bax, Bcl-2, Survivin, AKT 1, Beclin 1, EZH2, and LMP 1. Univariate and multivariate analyses confirmed that Aurora-A, MMP-9 and C-Met were independent prognostic biomarker to predict NPC recurrence (with all P < 0.05). For CNE-1 and CNE-2 NPC cells, VX-680, an Aurora-A specific inhibitor, and SU11274, a specific C-Met inhibitor, combined treatment significantly increased NPC cell sensitivity to radiation. Moreover, the similar results were also observed in NPC nude mice xenograft mode. We had construct the Aurora-A/C-met high expressed and Aurora-A/C-met low expressed PDX SCID mice, the combined therapeutic effect to radiation are ongoing testing. Conclusions: Based on this nonbiased method, we identified Aurora-A, C-Met and MMP-9 were the potential prognostic biomarker to predict NPC recurrence. Target Aurora-a and C-met with their specific inhibitor sensitized the NPC cell and tumor xenograft mice model to radiation, suggesting a promising way to upregulate radiosensitivity and abate radioresistant residue induced recurrence for nasopharyngeal carcinoma.

Irradiation-induced dynamic changes of gene signatures reveal gain of metastatic ability in nasopharyngeal carcinoma.

Identification of Prognostic Biomarkers for Response to Radiotherapy by DNA Microarray in Nasopharyngeal Carcinoma Patients

Ionizing Radiation Promotes Advanced Malignant Traits in Nasopharyngeal Carcinoma Via Activation of Epithelial-Mesenchymal Transition and the Cancer Stem Cell Phenotype.

Key radioresistance regulation models and marker genes identified by integrated transcriptome analysis in nasopharyngeal carcinoma

Radiosensitivity-Related Genes and Clinical Characteristics of Nasopharyngeal Carcinoma

Immune dysregulation underpins radioresistance in nasopharyngeal carcinoma (NPC).

RNA-Seq Analysis of Peripheral Blood Mononuclear Cells Reveals Unique Transcriptional Signatures Associated with Radiotherapy Response of Nasopharyngeal Carcinoma and Prognosis of Head and Neck Cancer

[Irradiation induced epithelial-mesenchymal transition in nasopharyngeal carcinoma in vitro]

Abstract 5241: p38 MAPK/EGR1/PD-L1 axis promotes radiation resistance of nasopharyngeal carcinoma by enhancing immune evasion

Increased Angiogenin Expression Correlates with Radiation Resistance and Predicts Poor Survival for Patients with Nasopharyngeal Carcinoma

Genome-Wide Analyses of Radioresistance-Associated Mirna Expression Profile in Nasopharyngeal Carcinoma Using Next Generation Deep Sequencing

Dual role of targeting NAE1 in nasopharyngeal carcinoma: Antitumor effects yet inducing radiotherapy resistance

Integrated Analysis of Differential Mirna and Mrna Expression Profiles in Human Radioresistant and Radiosensitive Nasopharyngeal Carcinoma Cells.

Identification of Aurora-A and C-Met As Recurrence Predictor and Therapeutic Target for Nasopharyngeal Carcinoma.

The Role of Enhanced Radiosensitivity and Tumor-Specific Suicide Gene Vector in Genetherapy of Nasopharyngeal Carcinoma

SPP1+ tumor-associated macrophages induce radioresistance of nasopharyngeal carcinoma through crosstalk with the tumor microenvironment

lncRNA CASC19 Contributes to Radioresistance of Nasopharyngeal Carcinoma by Promoting Autophagy via AMPK-mTOR Pathway

The promising role of miRNAs in radioresistance and chemoresistance of nasopharyngeal carcinoma

Transcriptional pausing induced by ionizing radiation enables the acquisition of radioresistance in nasopharyngeal carcinoma

MicroRNA-372 Enhances Radiosensitivity While Inhibiting Cell Invasion and Metastasis in Nasopharyngeal Carcinoma Through Activating the PBK-dependent P53 Signaling Pathway

Cancer-associated fibroblasts promote the survival of irradiated nasopharyngeal carcinoma cells via the NF-κB pathway